(PharmaNewsWire.Com, September 17, 2019 ) According to the new market research report "Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region - Global Forecast to 2024", published by MarketsandMarkets™
Report Objectives:
- To define, describe, and forecast the regenerative medicine market on the basis of type, application, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities)
- To strategically analyse micromarkets with respect to individual growth trends, prospects, and contributions to the overall regenerative medicine market
- To analyse market opportunities for stakeholders and provide details of the competitive landscape for key players
Cell-based immunotherapy & cell therapy products segment dominated the Regenerative Medicine Market in 2019.
On the basis of type, the Regenerative Medicine Market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products. The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.
Browse and in-depth TOC on "Regenerative Medicine Market"
76 - Tables
29 - Figures
107 - Pages
Recent developments:
- In 2018, Novartis received EU approval for one-time gene therapy Luxturna, which has been developed to restore vision in people with rare and genetically-associated retinal disease
- In 2018, Novartis received EU approval for its CAR-T cell therapy, Kymriah.
- In 2017, Integra LifeSciences launched its product, Integra Dermal Regeneration Template Single Layer "Thin" for dermal repair defects reconstruction in a one-step procedure.
North America anticipated to account for the largest share of the Regenerative Medicine Market in 2019.
The Regenerative Medicine Market in North America is expected account for the largest share globally, and also grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine, introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.
The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this Regenerative Medicine Market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
